Commentary

Page 5

Recently published articles about Commentary

JCP
Bipolar Disorder and PMDD: Comorbidity Conundrum
Commentary

October 26, 2022

Teri Pearlstein, MD, discusses a recent review that highlights the difficulties of diagnosing PMDD in women with bipolar disorder.
JCP
Relationship Between MDD and Medical Conditions
Commentary

October 19, 2022

This commentary by Rachel A. Weir, MD, and Mark Hyman Rapaport, MD, discusses the article by Alix M. Arnaud, MSc, and colleagues on the overlap between major depressive disorder...
,
JCP
Lost in Translation: The Value of Psychiatric Clinical Trials
Commentary

October 17, 2022

John C. Markowitz, MD, and Barbara L. Milrod, MD, assert the value of clinical trials in psychiatry and outline reasons why NIMH should resume supporting them.
,
JCP
Ketamine in the Real World: Where Do We Go From Here?
Commentary

September 14, 2022

Dr Wilkinson comments on recent data and developments in the use of ketamine for mood disorders.
JCP
Positive Predictive Value
Commentary

August 24, 2022

In this Commentary, the author posits that knowledge about positive predictive value—the probability a person identified as ill by a screening test does indeed have the illness—is important for...
JCP
Psychiatric Care Considerations for Sexually and Gender Diverse Populations
Commentary

July 18, 2022

Dr Keuroghlian discusses recent research by Oka et al on LGBTQ patients’ clinical characteristics and response to ECT.

Watch the New PsychCase360

Explore two real-world schizophrenia cases
Promotional banner for a video titled “Choosing the Right LAI for Patients With Schizophrenia” featuring headshots of Roueen Rafeyan, MD, and Melissa Vitale, PMHNP, with a “Watch Now” button.

Subscribe to read
more articles

Subscribe